VivoSim Labs, Inc. (VIVS)
0.281
0.00 (0.00%)
USD |
NASDAQ |
Sep 14, 14:38
VivoSim Labs Shareholders Equity (Quarterly) : -2.346M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.346M |
| March 31, 2026 | -1.099M |
| December 31, 2025 | 4.441M |
| September 30, 2025 | 7.065M |
| June 30, 2025 | 9.538M |
| March 31, 2025 | 10.49M |
| December 31, 2024 | 0.364M |
| September 30, 2024 | 3.68M |
| June 30, 2024 | 6.662M |
| March 31, 2024 | 3.601M |
| December 31, 2023 | 6.182M |
| September 30, 2023 | 8.456M |
| June 30, 2023 | 11.78M |
| March 31, 2023 | 15.33M |
| December 31, 2022 | 22.29M |
| September 30, 2022 | 25.01M |
| June 30, 2022 | 27.65M |
| March 31, 2022 | 30.21M |
| December 31, 2021 | 31.29M |
| September 30, 2021 | 34.21M |
| June 30, 2021 | 37.33M |
| March 31, 2021 | 39.20M |
| December 31, 2020 | 20.75M |
| September 30, 2020 | 19.99M |
| June 30, 2020 | 24.79M |
| Date | Value |
|---|---|
| March 31, 2020 | 26.63M |
| December 31, 2019 | 28.95M |
| September 30, 2019 | 31.07M |
| June 30, 2019 | 36.14M |
| March 31, 2019 | 36.30M |
| December 31, 2018 | 35.68M |
| September 30, 2018 | 38.87M |
| June 30, 2018 | 41.36M |
| March 31, 2018 | 44.59M |
| December 31, 2017 | 48.60M |
| September 30, 2017 | 52.06M |
| June 30, 2017 | 57.27M |
| March 31, 2017 | 62.36M |
| December 31, 2016 | 70.90M |
| September 30, 2016 | 52.49M |
| June 30, 2016 | 54.84M |
| March 31, 2016 | 62.18M |
| December 31, 2015 | 69.04M |
| September 30, 2015 | 76.15M |
| June 30, 2015 | 85.32M |
| March 31, 2015 | 48.70M |
| December 31, 2014 | 48.31M |
| September 30, 2014 | 53.43M |
| June 30, 2014 | 43.82M |
| March 31, 2014 | 48.28M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.847M |
| Total Liabilities (Quarterly) | 6.193M |
| Debt to Equity Ratio | -0.1347 |
| Current Ratio | 1.704 |
| Net Debt Paydown Yield | 4.41% |